Researchers evaluate that for the first time, report a significant decline in the rates of delayed discharge; and identified independent predictors of both delayed and early discharge post TAVR. Patients who stay in the hospital for more than 72 hours when undergoing trans-femoral transcatheter aortic valve replacement (TF-TAVR) procedure may be associated with negative short and long-term outcomes. The study was presented as late-breaking clinical science at the Society for Cardiovascular Angiography and Interventions (SCAI) 2018 Scientific Sessions.
More than five million Americans are diagnosed with heart valve disease each year (AHA). TAVR is a procedure used for patients with severe narrowing of the aortic vessel where a prosthetic valve is implanted, and the damaged valve is replaced. While the strategy of early discharge is important from the administrative and financial viewpoint; such practice may also come with additive clinical benefit regarding improved short and long-term outcomes.
Hence, this study aimed to investigate the trends, predictors, and outcomes associated with length of stay (LOS) post TF-TAVR. Patients undergoing non-aborted transfemoral TAVR, (n=32,847) and survived to discharge (n=24,285) in the TVT Registry from 2011-2015 were categorized as early discharge (ED<72 hours) or delayed discharge (DD). During the study period, there was a significant decline in the rates of DD.
The study for the first time delineates distinct independent predictors of early/late discharge (Multi-variate analysis) which Dr Wayangankar claims may have an immense impact on future care for aortic stenosis patients. The study also compared one-year outcomes based on LOS. DD post-TAVR was significantly associated with higher 1-year all-cause mortality with separation of curves noted immediately post procedure. Even after adjusting for in-hospital complications, DD was an independent predictor of 1-year all-cause mortality.
The authors conclude that data from their study (predictors) should be prospectively validated within the TVT registry. Once validated, LOS calculators could help streamline TAVR programs across the world and would help make aortic stenosis care efficient, optimized and sustainable.
"The predictors from our study could have a huge impact on the future clinical care of TAVR patients," said Siddharth Wayangankar, MD, University of Florida. "Pre-TAVR, these predictors could be used to develop bedside risk scores for LOS. These could help physicians in patient selection, procedural and post-procedural planning based on patient-specific variables. On a much bigger front, these risk scores could be used by administrators, third-party payors and policymakers for formulating coverage for TAVR procedures and evaluating bundle payments."
Dr Wayangankar believes the study results have immense post-TAVR implications too. Considering the strong association of DD and outcomes at one year; patients with DD may require a more rigorous follow-up schedule to mitigate the higher mortality and hospitalization rates.